|

E²-RADIatE: EORTC-ESTRO RADiotherapy InfrAstrucTure for Europe

RECRUITINGSponsored by European Organisation for Research and Treatment of Cancer - EORTC
Actively Recruiting
SponsorEuropean Organisation for Research and Treatment of Cancer - EORTC
Started2019-06-24
Est. completion2026-04-30
Eligibility
Age12 Years+
View on ClinicalTrials.gov →

NCT03818503

Summary

The primary objective is the collection of real-world data of cancer patients treated with radiotherapy, to support radiotherapy research and to provide evidence of the role of radiation oncology in a multidisciplinary approach. This is an open ended prospective non-interventional non-therapeutic multi-cohort study.

Eligibility

Age: 12 Years+
Inclusion Criteria:

* Pathologically confirmed cancer.
* Written informed consent for E²-RADIatE according to applicable legal and ethical requirements
* Planned use of radiotherapy
* Eligibility of the patient confirmed for at least one cohort confirmed
* Patients of 12 years and older

Conditions1

Cancer

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.